FACULTY OF BUSINESS AND ACOUNTANCY
BACHELOR OF BUSINESS ADMINISTRATION
CBEB 1106 PRINCIPLES OF MARKETING
Assignment 2012/2013
Company Case: Unilab’s Vidastat
Prepare by:
Choong Yee Ping CEB120013
Kim Ga Young NEX120217
Lim Ke Shin CEB120032
Nurfarah Ain Bt. Abu Hassan SEF090030
Contents Number | Tittle | Pages Number | 1.1 | Introduction | | | 1.1.1 The Price Buster | 3 | | 1.1.2 Company Background | 4 | | 1.1.3 Competitor’s Analysis | 5-6 | | 1.1.4 Unilab Launches a Counteroffensive | 7-9 | 1.2 | Question for Discussion | | | 1.2.1 Question 1 | 10 | | 1.2.2 Question 2 | 11-12 | | 1.2.3 Question 3 | 13 | | 1.2.4 Question 4 | 14-15 | 1.3 | Conclusion | 16 | 1.4 |
…show more content…
In 2005, Zocor was Merck’s number-one product and the second-biggest anti-cholesterol product, with worldwide sales of $4.3 billion. Zocor enjoyed a first mover advantage, thereby becoming the market leader in the anti-cholesterol segment. In 2004, Merck’s patent on simvastatin expired and it became a generic product, whereby other companies could now manufacture and market simvastatin in different countries and with brand names without paying any royalties to the previous patent holder. Merck expected a decline in its sales as a result of the proliferation of generic , produced by different companies.
Zocor had been promoted not only in Asia but all over the world, and doctors were happy to prescribe the drug as it proved to effectively reduce the risk of heart attacks and strokes among patients by reducing cholesterol.
Based on clinical studies, simvastation has to be taken continuously for three months to reduce high cholesterol to a normal level, Other competitors’ alternatives-such as fish oil capsules, which are sometimes called the “natural anti-cholesterol agent”-were not as popular as simvastatin and were not being prescribed by doctors. Zocor was the market leader, securing more then 35 percent of the Philippines’ anti-cholesterol market. Zocor was promoted by a strong sales team who regularly met with doctor to explain the merits of the drug. The sales team also carried out sampling and distributed promotional material including brochures and free
Many studies were conducted on coronary artery disease (CAD) because it is the leading cause of mortality and premature disability so studies investigated those at risk of coronary atherosclerosis aiming to provide early treatment (Kolovou et al., 2005), (Akhabue et al., 2014).
According to the CDC, cardiovascular disease claims 614,348 lives in 2014 making it the leading cause of death in the United States, accounting for 46.9% of all deaths in 2014. This percentage is estimated to increase threefold by the end of 2016 (Heron, 2016). This is a significant issue, mainly because, for the most part this is a preventable ailment. If not closely control, this can quickly become an epidemic as the overall death rate increase each year. To fully understand this disease, we need to first look at the root cause, coronary artery disease.
Smashburger is a rapidly expanding burger restaurant concept; they have announced a summary of its 2011 accomplishments and their marketing and expansion plans for 2012. Opening their first location in 2007 and growing rapidly ever since, now in 2011 Smashburger had yet another successful year of growth and consumer acceptance. Smashburger is quickly gaining national recognition for its juicy handmade burgers that are smashed fresh and served delicious, along with its localized recipes that celebrate regional taste profiles in
Cardiovascular disease (CVD), a leading cause of mortality and morbidity in Australia, affects 22% of the Australian population. Targeting this health
1. As a marketing consultant for a chain of hair salons, you have been asked to evaluate the kids’ market as a potential segment for the chain to target. Evaluate the kids’ segment against the four criteria for successful market segmentation.
“Suppose your doctor got your lab work and said your cholesterol is high with this type of thing it can cause risk of heart attack and cardiovascular disease then he prescribes you a pill called statin. However, ask yourself if the drug is worth it because the statistics only help 30-50 percent of people who consume the drug.” Said Levitin. This quote makes you think about if the solution is really worth it because by a slim chance the drug can help or even cure you disease you contain in your body, and that doesn’t seem right if you are wasting money if you’re not getting help from the drug. This piece of evidence supports my opinion by ten full because you’ll be making big mistake if you buy a drug that may help your disease or disability, and the statistics are not in your favor. However, be smart and ask the doctor any type of questions that may affect you by any
Since 1960 the age-adjusted mortality rates for cardiovascular disease (CVD) has declined steadily in the U.S. due to multiple factors, but still remains one of the primary causes of morbidity and premature mortality worldwide. Greater control of risk factors and improved treatments for cardiovascular disease has significantly contributed to this decline (Centers for Disease Control and Prevention, 2011). In the U.S. alone it claims approximately 830,000 each year and accounts for 1/6 of all deaths under the age of 65 (Weiss and Lonnquist, 2011). Based on the 2007 mortality rate data an average of 1 death every 37 seconds is due to cardiovascular disease (Lloyd-Jones et al., 2009). Controlling and reducing risk factors is crucial for
The increase in cholesterol screening suggests that a community level reduction in cardiovascular disease risk may be achievable through low cost intervention combined with education efforts and compliance. Moreover, this is a cost effective and health promotion program, which can be provide by nurse or health educators rather the physician
You will provide your completed assessment for all of Part One in one document with cover page (included in this assessment tool on page 2). You are required to professionally format your document including spell-check and indicating each Task answer [e.g. Task 1 (a.) then the answer, Task 1 (b.) then the answer etc.] according to this Assessment Tool Task requirement. You may lose marks if you have not spell-checked your document (as this is a professional formatting requirement, a business skill). Whenever conducting a Presentation, you must always provide copies of MS PowerPoint slides as evidence for your Trainer/Assessor. Be sure to properly reference your sources of information using the Harvard referencing system. For more information go to:1. Student Handbook - latest version 2. AIPE Connect online resources; or 3. Ask your Trainer/Assessor to provide you with this information In order to determine if you are addressing this assessment adequately in terms of competency/comprehension (prior to due date) a draft copy of your assessment should be discussed during class time in consultation with your Trainer/Assessor. For this feedback/ support from your Trainer/Assessor, you will need to bring to class your “draft copy” with any evidence of the research you have conducted to produce the assessment. AIPE accommodates students with reasonable adjustments to training and assessment. This could include variations in course delivery or assessment methodology and it
Preventative measures are complex and may include basic lifestyle modifications. Some modifications include increased physical activity, improved diet, drug treatments and smoking cessation. Drug treatments, such as a low dosage aspirin regimen, are widely used in clinical practice for secondary prevention after a patient experiences a stroke or myocardial infarction. Low-dose aspirin is used more often as a primary prevention measure for CVD to prevent the onset of life-threatening occurrences (Stegeman et al., 2015). However, aspirin use is advised to be monitored, especially in patients that are already at risk for CVD. Education regarding the usage of drugs for treatment should be enforced to ensure a user’s safety (Stegeman et al., 2015). Selective treatment of women around the age of 65 or older with aspirin has been observed to improve the risk of CVD (Van Kruijsdijk et al.,
Zocor is the brand name of simvastatin, developed by an American company called Merck & Co. Originally, the research was done by a biochemist named Akira Endo in the Sankyo Company. This drug is now used to treat various lipid disorders and patients at high risk for Coronary Heart Disease (CHD).
This analysis paper will explain if Dr. DoRight of Universal Human Care Hospital can manage when he discovers that patients inside the hospital are dying as a results of a extent of illegal practices by doctors, nurses and careless supervision of oversight on their be half. Also question the rights of staff to health and safety within the work place and address the duty of loyalty, and conflicts of interest between internal and external
Atherosclerosis is commonly referred to as the principal cause of death in the developed world. Although deaths attributed to CVD have reduced significantly over the last 10 years, atherosclerosis is still one of the leading causes of mortality, both globally and in the UK. The World Health Organisation (2014) reports that CVD accounted for 17.5 million deaths in 2012. According to the Office for National Statistics (2013) circulatory diseases, including heart disease and strokes, were the cause of 28% of all deaths in England & Wales during the year 2013. Deaths due to atherosclerosis are expected to rise in the UK due to the rising elderly population and obesity epidemic, thus treatments that can reverse the atherosclerotic process will be of benefit to many millions of patients.